These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

826 related articles for article (PubMed ID: 24310172)

  • 1. Recognition of lipopolysaccharide pattern by TLR4 complexes.
    Park BS; Lee JO
    Exp Mol Med; 2013 Dec; 45(12):e66. PubMed ID: 24310172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic lipopolysaccharide transfer cascade to TLR4/MD2 complex via LBP and CD14.
    Kim SJ; Kim HM
    BMB Rep; 2017 Feb; 50(2):55-57. PubMed ID: 28115037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex.
    Park BS; Song DH; Kim HM; Choi BS; Lee H; Lee JO
    Nature; 2009 Apr; 458(7242):1191-5. PubMed ID: 19252480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Thermodynamic Funnel Drives Bacterial Lipopolysaccharide Transfer in the TLR4 Pathway.
    Huber RG; Berglund NA; Kargas V; Marzinek JK; Holdbrook DA; Khalid S; Piggot TJ; Schmidtchen A; Bond PJ
    Structure; 2018 Aug; 26(8):1151-1161.e4. PubMed ID: 29779787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstruction of LPS Transfer Cascade Reveals Structural Determinants within LBP, CD14, and TLR4-MD2 for Efficient LPS Recognition and Transfer.
    Ryu JK; Kim SJ; Rah SH; Kang JI; Jung HE; Lee D; Lee HK; Lee JO; Park BS; Yoon TY; Kim HM
    Immunity; 2017 Jan; 46(1):38-50. PubMed ID: 27986454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide Recognition in the Crossroads of TLR4 and Caspase-4/11 Mediated Inflammatory Pathways.
    Zamyatina A; Heine H
    Front Immunol; 2020; 11():585146. PubMed ID: 33329561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide (LPS)-binding protein stimulates CD14-dependent Toll-like receptor 4 internalization and LPS-induced TBK1-IKKϵ-IRF3 axis activation.
    Tsukamoto H; Takeuchi S; Kubota K; Kobayashi Y; Kozakai S; Ukai I; Shichiku A; Okubo M; Numasaki M; Kanemitsu Y; Matsumoto Y; Nochi T; Watanabe K; Aso H; Tomioka Y
    J Biol Chem; 2018 Jun; 293(26):10186-10201. PubMed ID: 29760187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis of the host response to lipopolysaccharide.
    Bryant CE; Spring DR; Gangloff M; Gay NJ
    Nat Rev Microbiol; 2010 Jan; 8(1):8-14. PubMed ID: 19946286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the LPS/TLR4 signal pathway with small molecules.
    Peri F; Piazza M; Calabrese V; Damore G; Cighetti R
    Biochem Soc Trans; 2010 Oct; 38(5):1390-5. PubMed ID: 20863319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial responses to endotoxins and Gram-negative bacteria.
    Heumann D; Roger T
    Clin Chim Acta; 2002 Sep; 323(1-2):59-72. PubMed ID: 12135807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the TLR4-associated protein MD-2 using yeast-display and mutational analyses.
    Mattis DM; Chervin AS; Ranoa DR; Kelley SL; Tapping RI; Kranz DM
    Mol Immunol; 2015 Dec; 68(2 Pt A):203-12. PubMed ID: 26320630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial lipopolysaccharides and innate immunity.
    Alexander C; Rietschel ET
    J Endotoxin Res; 2001; 7(3):167-202. PubMed ID: 11581570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2.
    Ohto U; Fukase K; Miyake K; Shimizu T
    Proc Natl Acad Sci U S A; 2012 May; 109(19):7421-6. PubMed ID: 22532668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists.
    Peri F; Piazza M
    Biotechnol Adv; 2012; 30(1):251-60. PubMed ID: 21664961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells.
    Tsukamoto H; Fukudome K; Takao S; Tsuneyoshi N; Kimoto M
    Int Immunol; 2010 Apr; 22(4):271-80. PubMed ID: 20133493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of lipid A variants by the TLR4-MD-2 receptor complex.
    Maeshima N; Fernandez RC
    Front Cell Infect Microbiol; 2013; 3():3. PubMed ID: 23408095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of binding of LPS to recombinant CD14, TLR4, and MD-2 proteins.
    Shin HJ; Lee H; Park JD; Hyun HC; Sohn HO; Lee DW; Kim YS
    Mol Cells; 2007 Aug; 24(1):119-24. PubMed ID: 17846506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide binding protein/CD14/ TLR4-dependent recognition of salmonella LPS induces the functional activation of chicken heterophils and up-regulation of pro-inflammatory cytokine and chemokine gene expression in these cells.
    Kogut MH; He H; Kaiser P
    Anim Biotechnol; 2005; 16(2):165-81. PubMed ID: 16335810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of toll-like receptor 4. Insights from x-ray crystallography and molecular modeling.
    Klett J; Reeves J; Oberhauser N; Pérez-Regidor L; Martín-Santamaria S
    Curr Top Med Chem; 2014; 14(23):2672-83. PubMed ID: 25515751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.